Načítá se...
Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?
OBJECTIVE: To explore whether a panel of kallikrein markers in blood: total, free and intact prostate-specific antigen (PSA) and kallikrein-related peptidase 2, could be used as a non-invasive alternative for predicting prostate cancer on biopsy in a screening setting. SUBJECTS AND METHODS: The stud...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3675187/ https://ncbi.nlm.nih.gov/pubmed/23448270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2012.11690.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|